subscribeSubscribe
Getting patented meds on NLEM list an uphill battle says committee member

Getting patented meds on NLEM list an uphill battle says committee member
Teena Thacker ECONOMIC TIMES
15 Sep 2022
Share Share
AbbVie inks licensing deal to boost Mavyret access in nearly 100 countries

AbbVie inks licensing deal to boost Mavyret access in nearly 100 countries
Eric Sagonowsky FIERCE PHARMA
14 Nov 2018
Share Share
List of centrally authorised products requiring a notification of a change for update of annexes

List of centrally authorised products requiring a notification of a change for update of annexes
EMA
12 Oct 2018
Share Share
Natco Pharma launches Hepatitis C drug in India

Natco Pharma launches Hepatitis C drug in India
ECONOMIC TIMES
03 Jul 2018
Share Share
Epclusa`s fast-tracked Chinese approval might be late for Gilead

Epclusa`s fast-tracked Chinese approval might be late for Gilead
Angus Liu FIERCE PHARMA
31 May 2018
Share Share
Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report

Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report
Angus Liu FIERCE PHARMA
06 Jan 2018
Share Share
Bristol-Myers Squibb receives CFDA approval for all-oral regimen for HCV Daklinza in combo with Sunvepra

Bristol-Myers Squibb receives CFDA approval for all-oral regimen for HCV Daklinza in combo with Sunvepra
PHARMABIZ
02 May 2017
Share Share
EU Health Regulator Warns Some Hep C Drugs Could Reactivate Hep B

EU Health Regulator Warns Some Hep C Drugs Could Reactivate Hep B
VL Nathan REUTERS
03 Dec 2016
Share Share
Mylan Signs Sub-license Agreement with the Medicines Patent Pool

Mylan Signs Sub-license Agreement with the Medicines Patent Pool
PR NEWSWIRE
28 Nov 2016
Share Share
Recent Success in HCV Treatment Brings Relief to Patients

Recent Success in HCV Treatment Brings Relief to Patients
DRUG DEVELOPMENT
07 Nov 2016
Share Share